Jameel Health announces a strategic acquisition of a majority stake in Genpharm, a leading partner for rare disease market access in the Middle East
Abdul Latif Jameel Health to collaborate with EQRx to introduce two novel and affordable cancer treatments at a fraction of the cost of existing approaches to 1.5 billion people across the Middle East, Turkey and Africa
